The Enterococcus hirae CopB ATPase (EC 3.6.1.3) confers copper resistance t
o the organism by expelling excess copper. Two related human ATPase genes,
ATP7A (EC 3.6.1.36) and ATP7B (EC 3.6.1.36), have been cloned as the loci o
f mutations causing Menkes and Wilson diseases, diseases of copper metaboli
sm. Many mutations in these genes have been identified in patients. Since i
t has not yet been possible to purify the human copper ATPases, it has prov
ed difficult to test the impact of mutations on ATPase function. Some mutat
ions occur in highly conserved sequence motifs, suggesting that their effec
t on function can be tested with a homologous enzyme. Here, we used the E.
hirae CopB ATPase to investigate the impact of such mutations on enzyme fun
ction in vivo and in vitro. The Menkes disease mutation of Cys-1000 --> Arg
, changing the conserved Cys-Pro-Cys ('CPC') motif, was mimicked in CopB. T
he corresponding Cys-396 --> Ser CopB ATPase was unable to restore copper r
esistance in a CopB knock-out mutant in vivo. The purified mutant ATPase st
ill formed an acylphosphate intermediate, but possessed no detectable ATP h
ydrolytic activity. The most frequent Wilson disease mutation, His-1069 -->
Gln, was introduced into CopB as His-480 --> Gin (H480Q). This mutant CopB
also failed to confer copper resistance to a CopB knock-out strain. Purifi
ed H480Q CopB formed an acylphosphate intermediate and retained a small, bu
t significant, ATPase activity. Our results reveal that Cys-396 and His-480
of CopB are key residues for ATPase function, and similar roles are sugges
ted for Cys-1000 and His-1069 of Menkes and Wilson ATPases respectively.